These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2023222)

  • 1. Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout.
    Wallace SL; Singer JZ; Duncan GJ; Wigley FM; Kuncl RW
    J Rheumatol; 1991 Feb; 18(2):264-9. PubMed ID: 2023222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine for acute gout.
    McKenzie BJ; Wechalekar MD; Johnston RV; Schlesinger N; Buchbinder R
    Emergencias; 2023 Aug; 35(4):297-299. PubMed ID: 37439423
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose colchicine for chronic stable atherosclerosis: Under-appreciated and under-prescribed.
    Ridker PM
    Eur J Intern Med; 2024 Jul; 125():36-38. PubMed ID: 38762433
    [No Abstract]   [Full Text] [Related]  

  • 4. Colchicine poisoning: the dark side of an ancient drug.
    Finkelstein Y; Aks SE; Hutson JR; Juurlink DN; Nguyen P; Dubnov-Raz G; Pollak U; Koren G; Bentur Y
    Clin Toxicol (Phila); 2010 Jun; 48(5):407-14. PubMed ID: 20586571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of gouty arthritis in patients with chronic kidney disease.
    Abdellatif AA; Elkhalili N
    Am J Ther; 2014; 21(6):523-34. PubMed ID: 22960848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine myopathy and neuropathy.
    Kuncl RW; Duncan G; Watson D; Alderson K; Rogawski MA; Peper M
    N Engl J Med; 1987 Jun; 316(25):1562-8. PubMed ID: 3035372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine-Induced Acute Myopathy: Case Study From Saudi Arabia.
    Al Megalli M; Bashir S; Qadah H; Ameen O; Al-Harbi TM
    Cureus; 2021 Dec; 13(12):e20290. PubMed ID: 35028201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease.
    Robinson PC; Terkeltaub R; Pillinger MH; Shah B; Karalis V; Karatza E; Liew D; Imazio M; Cornel JH; Thompson PL; Nidorf M
    Am J Med; 2022 Jan; 135(1):32-38. PubMed ID: 34416165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of colchicine in the complications of COVID19. Could the immunometabolic properties of an old and cheap drug help?
    Ribeiro SA; Lopes C; Amaral R; Amaral A
    Metabol Open; 2020 Sep; 7():100045. PubMed ID: 32808940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine-Induced Rhabdomyolysis: Clinical, Biochemical, and Neurophysiological Features and Review of the Literature.
    Fernández-Cuadros ME; Goizueta-San-Martin G; Varas-de-Dios B; Casique-Bocanegra LO; Manrique-de-Lara-Cadiñanos P; Albaladejo-Florin MJ; Algarra-López R; Pérez-Moro OS
    Clin Med Insights Arthritis Musculoskelet Disord; 2019; 12():1179544119849883. PubMed ID: 31244525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.
    Vargas-Santos AB; Castelar-Pinheiro Gda R; Coutinho ES; Schumacher HR; Singh JA; Schlesinger N
    PLoS One; 2015; 10(8):e0135805. PubMed ID: 26274585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease.
    Wason S; Mount D; Faulkner R
    Clin Drug Investig; 2014 Dec; 34(12):845-55. PubMed ID: 25385362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database.
    Boonmuang P; Nathisuwan S; Chaiyakunapruk N; Suwankesawong W; Pokhagul P; Teerawattanapong N; Supsongserm P
    Drug Saf; 2013 Sep; 36(9):779-87. PubMed ID: 23615756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gout and organ transplantation.
    Stamp LK; Chapman PT
    Curr Rheumatol Rep; 2012 Apr; 14(2):165-72. PubMed ID: 22258500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenges of gout management in the elderly.
    Stamp LK; Jordan S
    Drugs Aging; 2011 Aug; 28(8):591-603. PubMed ID: 21812496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.
    Schlesinger N; Mysler E; Lin HY; De Meulemeester M; Rovensky J; Arulmani U; Balfour A; Krammer G; Sallstig P; So A
    Ann Rheum Dis; 2011 Jul; 70(7):1264-71. PubMed ID: 21540198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal amyloidosis in children.
    Bilginer Y; Akpolat T; Ozen S
    Pediatr Nephrol; 2011 Aug; 26(8):1215-27. PubMed ID: 21360109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.
    Nuki G
    Curr Rheumatol Rep; 2008 Jul; 10(3):218-27. PubMed ID: 18638431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine-induced rhabdomyolysis.
    Altman A; Szyper-Kravitz M; Shoenfeld Y
    Clin Rheumatol; 2007 Dec; 26(12):2197-2199. PubMed ID: 17619811
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.